Skip to main content
. Author manuscript; available in PMC: 2022 Oct 6.
Published in final edited form as: Cell Metab. 2022 May 10;34(6):805–817. doi: 10.1016/j.cmet.2022.04.010

Figure 3. Current clinical tools in the treatment of osteoporosis.

Figure 3.

There are several classes of drugs listed in this figure that can improve outcomes in osteoporosis. Each of these drug classes either inhibits bone resorption by osteoclasts or stimulates osteoblastic bone formation to improve bone mass and quality in osteoporotic patients. In addition to acting on only one arm of bone remodeling, each of these drugs has significant adverse side effects or limits on duration of use as represented in the figure. *The adverse side effects caused by each osteoporosis treatment.